↓ Skip to main content

Downstaging in Pancreatic Cancer: A Matched Analysis of Patients Resected Following Systemic Treatment of Initially Locally Unresectable Disease

Overview of attention for article published in Annals of Surgical Oncology, December 2011
Altmetric Badge

Citations

dimensions_citation
54 Dimensions

Readers on

mendeley
56 Mendeley
Title
Downstaging in Pancreatic Cancer: A Matched Analysis of Patients Resected Following Systemic Treatment of Initially Locally Unresectable Disease
Published in
Annals of Surgical Oncology, December 2011
DOI 10.1245/s10434-011-2156-7
Pubmed ID
Authors

K. A. Bickenbach, M. Gonen, Laura H. Tang, Eileen O’Reilly, Karyn Goodman, M. F. Brennan, M. I. D’Angelica, R. P. DeMatteo, Y. Fong, W. R. Jarnagin, P. J. Allen

Abstract

Patients with locally unresectable pancreatic cancer (AJCC stage III) have a median survival of 10-14 months. The objective of this study was to evaluate outcome of initially unresectable patients who respond to multimodality therapy and undergo resection.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 4%
Unknown 54 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 11%
Other 5 9%
Student > Ph. D. Student 5 9%
Professor 5 9%
Student > Bachelor 5 9%
Other 17 30%
Unknown 13 23%
Readers by discipline Count As %
Medicine and Dentistry 34 61%
Agricultural and Biological Sciences 1 2%
Social Sciences 1 2%
Engineering 1 2%
Unknown 19 34%